Skip to main content
SpringerLink
Log in

Hepatozelluläres Karzinom

  • Chapter
Die Onkologie

  • 343 Accesses

Zusammenfassung

Das hepatozelluläre Karzinom ist der weltweit vierthäufigste maligne Tumor mit einer Inzidenz von 20–150/100.000 Einwohner/Jahr in manchen Teilen von Asien und Afrika (Chen et al.1997). Es tritt wesentlich seltener in Westeuropa und in den Vereinigten Staaten (1–5/100.000 Einwohner/Jahr) auf, die niedrigste Inzidenz findet sich in Irland (0,1/100.000 Einwohner/Jahr). Es betrifft Männer im Schnitt 2- bis 4-mal häufiger als Frauen, wobei das Verhältnis ebenfalls geographischen Variationen unterliegt (Chen et al.1997).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.Gastroenterology 108: 768–775

    CAS  Google Scholar 

  • Altmann HW (1994) Hepatic neoformations.Pathol Res Pract 190: 513–577

    CAS  Google Scholar 

  • Barbot DJ, Marks JH, Feld RI, Liu JB, Rosato FE (1997) Improved staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg On-col 64: 63–67

    CAS  Google Scholar 

  • Barbu V, Bonnand AM, Hillaire Set al. (1997) Circulating albumin messenger RNA in hepatocellular carcinoma:results of a multicenter prospective study. Hepatology 26: 1171–1175

    PubMed  CAS  Google Scholar 

  • Baron RL, Oliver JH, Dodd GD, Nalesnik M, Holbert BL, Carr B (1996) Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199: 505–511

    PubMed  CAS  Google Scholar 

  • Bartolozzi C, Lencioni R, Caramella D, Palla A, Bassi AM, Di Candio G (1996) Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT. Acta Radiol 37: 69–74

    Google Scholar 

  • Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2: 1129–1133

    PubMed  CAS  Google Scholar 

  • Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214: 114–117

    PubMed  CAS  Google Scholar 

  • Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74: 2442–2448

    Google Scholar 

  • Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, Berman MD (1988) Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 95: 1399–1402

    PubMed  CAS  Google Scholar 

  • Boige V, Laurent Puig P, Fouchet P et al. (1997) Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 57: 1986–1990

    PubMed  CAS  Google Scholar 

  • Boix L, Bruix J, Castells A, Fuster I, Bru C, Visa J, Rivera F, Rodes J (1993) Sex hormone receptors in hepatocellular carcinoma.ls there a rationale for hormonal treatment? J Hepatol 17: 187–191

    PubMed  CAS  Google Scholar 

  • Brand R, Capadano M, Tempero M (1997) A phase 1 trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors. Invest New Drugs 15: 331–341

    PubMed  CAS  Google Scholar 

  • Brechot C, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B Virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286: 533–535

    PubMed  CAS  Google Scholar 

  • Bressac B, Galvin KM, Liang TJ, Isselbacher KI, WandsJR, Ozturk M (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 1973–1977

    CAS  Google Scholar 

  • Bruix J, Castells A, Bosch J et al. (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients:prognostic value of preoperative portal pressure. Gastroenterology 111: 1018–1022

    PubMed  CAS  Google Scholar 

  • Bruno S, Silini E, Crosignani A et al. (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25: 754–758

    PubMed  CAS  Google Scholar 

  • Buscarini L, Rossi S (1997) Technology for radiofrequency thermal ablation of liver tumors. Semin Laparosc Surg 4: 96–101

    PubMed  Google Scholar 

  • Calvet X, Bruix J, Brij C et al. (1990) Natural history of hepatocellular carcinoma in Spain. Five years’ experience in 249 cases. J Hepatol 10: 311–317

    PubMed  CAS  Google Scholar 

  • Calvet X, Bruix J, Ginés P, Brú C, Sole M, Vilana R, Rodes J (1990) Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 12: 753–760

    PubMed  CAS  Google Scholar 

  • Camma C, Giunta M, Andreone P, Craxi A (2001) Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.) Hepatol 34: 593–602

    CAS  Google Scholar 

  • Cao G, Kuriyama S, Du P, SakamotoT, Kong X, Masui K, Qi Z (1997) Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.Gastroenterology 112: 501–510

    CAS  Google Scholar 

  • Carr BI, Selby R, Madariaga J, Iwatsuki S, Starzl TE (1993) Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma.Transplant Proc 25: 1128–1129

    CAS  Google Scholar 

  • Carrasco D, Prieto M, Pallardò L, Moll JL, Cruz JM, Munoz C, Berenguer J (1985) Multiple hepatic adenomas after long-term therapy with testosterone enanthate.Review of the literature.J Hepatol 1: 573–578

    CAS  Google Scholar 

  • Castells A, Bruix J, Brú C et al. (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients:a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18: 1121–1126

    PubMed  CAS  Google Scholar 

  • Castells A, Bruix J, Brú C, Ayuso C, Roca M, Boix L, Vilana R, Rodes J (1995) Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 109: 917–922

    PubMed  CAS  Google Scholar 

  • Chang PC, Hu CP, Chen SH, Wang Wuu S, Chang C (1995) Deletion of integrated hepatitis B virus genome and cellular flanking sequences in hepatocellular carcinoma cells in BALB/c mice. Hepatology 21: 1504–1509

    PubMed  CAS  Google Scholar 

  • Chang MH, Chen CJ, Lai MS et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.Taiwan Childhood Hepatoma Study Group.N Engl J Med 336: 1855–1859

    CAS  Google Scholar 

  • Chen DS, Sung JL, Sheu JC et al. (1984) Serum alphafetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 86: 1404–1409

    PubMed  CAS  Google Scholar 

  • Chen CJ, Yu MW, LiawYF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12: 5294–5308

    Google Scholar 

  • Cherqui D, Piedbois P, Pierga JY et al.(1994)Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer 73: 2721–2726

    Google Scholar 

  • Collier J, Sherman M (1998) Screening for hepatocellular carcinoma. Hepatology 27: 273–278

    PubMed  CAS  Google Scholar 

  • Colombo M, de Franchis R, Del Ninno E et al. (1991) Hepatocellular carcino- ma in Italian patients with cirrhosis. N Engl J Med 325: 675–680

    PubMed  CAS  Google Scholar 

  • Cottone M, Marcenò MP, Maringhini A et al. (1983) Ultrasound in the diagnosis of hepatocellular carcinoma associated with cirrhosis. Radiology 147: 517–519

    PubMed  CAS  Google Scholar 

  • Cottone M, Turri M, Caltagirone M et al. (1994) Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 21: 1029–1034

    PubMed  CAS  Google Scholar 

  • Craig JR, Peters RL, Edmondson HA, Omata M (1980) Fibrolamellar carcinoma of the liver:a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46: 372–379

    PubMed  CAS  Google Scholar 

  • De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtie RL (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11: 447–449

    PubMed  Google Scholar 

  • Ding SF, Habib NA (1995) Loss of heterozygosity in liver tumours.J Hepatol 22: 230–238

    CAS  Google Scholar 

  • Dodd GD, Soulen MC, Kane RA et al. (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20: 9–27

    PubMed  Google Scholar 

  • Ebara M, Ohto M, Shinagawa T et al. (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis.A study in 22 patients. Gastroenterology 90: 289–298

    PubMed  CAS  Google Scholar 

  • Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48, 900 necropsies. Cancer 7: 462–503

    CAS  Google Scholar 

  • Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas asso- ciated with use of oral contraceptives. N Engl J Med 294: 470–472

    PubMed  CAS  Google Scholar 

  • Eggel H (1901) Über das primäre Carcinom der Leber. Beitr Pathol Anat 30: 506–604

    Google Scholar 

  • Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R (1990) Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol 11: 297–301

    PubMed  CAS  Google Scholar 

  • Fattovich G, Giustina G, Degos F etal. (1997a) Effectiveness of interferon alfa an incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action an Viral Hepatitis (EUROHEP).J Hepatol 27: 201–205

    PubMed  CAS  Google Scholar 

  • Fattovich G, Giustina G, Degos F et al. (1997b) Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112: 463–472

    PubMed  CAS  Google Scholar 

  • Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ (1988) Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut 29: 1603–1606

    PubMed  CAS  Google Scholar 

  • Figueras J, Jaurrieta E, Valls C et aí. (1997) Survival after liver transplantation in cirrhosic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25: 1485–1489

    PubMed  CAS  Google Scholar 

  • Fortunato L, Clair M, Hoffman J, Sigurdson ER, Sauter ER, Barber LW, Eisenberg B (1995) Is CT portography (CTAP) really useful in patients with liver tumors who undergo intraoperative ultrasonography (IOUS)? Am Surg 61: 560–565

    PubMed  CAS  Google Scholar 

  • Freeny PC, Nghiem HV, Winter TC (1995) Helical CT during arterial portography: optimization of contrast enhancement and scanning parameters. Radiology 194: 83–90

    PubMed  CAS  Google Scholar 

  • Gaa J, Fischer H, Laub G, Georgi M (1996a) Breath-hold MR imaging of focal liver lesions: comparison of fast and ultrasound techniques. Eur Radiol 6: 838–843

    PubMed  CAS  Google Scholar 

  • Gaa J, Hatabu H, Jenkins RL, Finn JP, Edelman RR (1996b) Liver masses: replacement of conventional T2-weighted spin- echo MR imaging with breath-hold MR imaging. Radiology 200: 459–464

    PubMed  CAS  Google Scholar 

  • Gagliardi A, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 53: 533–535

    PubMed  CAS  Google Scholar 

  • Galle PR, Hofmann WJ, Walczak H et al. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182: 1223–1230

    PubMed  CAS  Google Scholar 

  • Ghendon Y (1987) Perinatal transmission of hepatitis B Virus in high-incidence countries. J Virol Methods 17: 69–79

    PubMed  CAS  Google Scholar 

  • Graziadei I, Kelly T, Schirmer M, Geisen FH, Vogel W, Konwalinka G (1998) Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2;2’-difluorodeoxycytidine an human hepatoma HepG2 cells. J Hepatol28: 504–509

    Google Scholar 

  • Grigsby P, Meyer JS, Sicard GA, Huggins MB, Lamar DJ, DeSchryverKecskemeti K (1987) Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives.) Surg Oncol 35: 173–179

    CAS  Google Scholar 

  • Grimaldi C, Bleiberg H, Gay F et al. (1998) Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial.) Clin Oncol 16: 411–417

    CAS  Google Scholar 

  • Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256–1261

    Google Scholar 

  • Hamois DM, Steers J, Andrews JC et al. (1999) Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5: 192–199

    Google Scholar 

  • Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K (1995) The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 22: 1702–1707

    PubMed  CAS  Google Scholar 

  • Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein ( LHBs) is a transcriptional activator. Virology 225: 235–239

    Google Scholar 

  • Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R (1994) Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 106: 239–242

    PubMed  CAS  Google Scholar 

  • Hollstein M, Marion MJ, Lehman T et al. (1994) p53 mutations at a:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 15: 1–3

    Google Scholar 

  • Hosoki T, Mitomo M, Chor S, Miyahara N, Ohtani M, Morimoto K (1997) Visualization of tumor vessels in hepatocellular carcinoma. Power Doppler compared with color Doppler and angiography. Acta Radiol 38: 422–427

    Google Scholar 

  • Huber BE, Richards CA, Krenitsky TA (1991) Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 88: 8039–8043

    PubMed  CAS  Google Scholar 

  • Hwang GJ, Kim MJ, Yoo HS, ‘Lee JT (1997) Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 202: 383–388

    CAS  Google Scholar 

  • Hytiroglou P, Kotoula V, Thung SN, Tsokos M, Fiel MI, Papadimitriou CS (1998) Telomerase activity in precancerous hepatic nodules. Cancer 82: 1831–1838

    PubMed  CAS  Google Scholar 

  • Ikeda K, Saitoh S, Koida I et al. (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47–53

    PubMed  CAS  Google Scholar 

  • Ishiguchi T, Shimamoto K, Fukatsu H, Yamakawa K, Ishigaki T (1996) Radio-logic diagnosis of hepatocellular carcinoma. Semin Surg Oncol 12: 164–169

    PubMed  CAS  Google Scholar 

  • Ito Y, Kojiro M, Nakashima T, Mori T (1988) Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 62: 1153–1162

    PubMed  CAS  Google Scholar 

  • Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE (1985) Role of liver transplantation in cancer therapy. Ann Surg 202: 401–407

    PubMed  CAS  Google Scholar 

  • Iwatsuki S, Starzl TE, Sheahan DG et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma.Ann Surg 214:221–228; discussion 228–229

    Google Scholar 

  • lzumi R, Shimizu K, li T, Yagi M, Matsui O, Nonomura A, Miyazaki I (1994a) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106: 720–727

    Google Scholar 

  • Izumi R, Shimizu K, Lyobet et al. (1994b) Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20: 295–301

    PubMed  CAS  Google Scholar 

  • John TG, Greig JD, Crosbie JL, Miles WF, Garden OJ (1994) Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg 220: 711–719

    PubMed  CAS  Google Scholar 

  • Kanematsu M, Hoshi H, Murakami T et al. (1997) Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. Am J Roentgenol 169: 1507–1515

    Google Scholar 

  • Kanematsu M, OliverJH, Carr B, Baron RL (1997) Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography. Radiology 205: 75–80

    PubMed  CAS  Google Scholar 

  • Kaplanski C, Chisari FV, Wild CP (1997a) Minisatellite rearrangements are increased in liver tumours induced by transplacental aflatoxin B1 treatment of hepatitis B virus transgenic mice, but not in spontaneously arising tumours. Carcinogenesis 18: 633–639

    PubMed  CAS  Google Scholar 

  • Kaplanski C, Srivatanakul P, Wild CP (1997b) Frequent rearrangements at minisatellite loci D1S7 (1p33–35), D7S22 (7836-ter) and D12511 (12824.3-ter) in hepatitis B virus-positive hepatocellular carcinomas from Thai patients. Int J Cancer 72: 248–254

    PubMed  CAS  Google Scholar 

  • Kar S, Carr BI (1995) Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 21: 403–407

    PubMed  CAS  Google Scholar 

  • Kasahara A, Hayashi N, Mochizuki K et al. (1998) Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 27: 1394–1402

    Google Scholar 

  • Kew MC (1996a) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16: 395–406

    PubMed  CAS  Google Scholar 

  • Kew MC (1996b) Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 38 [Suppl 2]: 531–36

    Google Scholar 

  • Kew MC (1996c) Recurrence of hepatocellular carcinoma after surgery:can it be avoided? Hepatology 24: 741–742

    PubMed  CAS  Google Scholar 

  • Kew MC, Song E, Mohammed A, Hodkinson J (1990) Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women. Hepatology 11: 298–302

    PubMed  CAS  Google Scholar 

  • Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317–320

    PubMed  CAS  Google Scholar 

  • Kim T, Murakami T, Oi H et al. (1995) Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput AssistTomogr 19: 948–954

    PubMed  CAS  Google Scholar 

  • Kim AY, Choi BI, Kim TK, Han JK, Yun EJ, Lee KY, Han MC (1998) Hepatocellular carcinoma: power Doppler US with a contrast agent–preliminary results. Radiology 209: 135–140

    PubMed  CAS  Google Scholar 

  • Kirby GM, Batist G, Fotouhi Ardakani N et al. (1996) Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis. Int J Cancer 68: 21–25

    PubMed  CAS  Google Scholar 

  • Kita R, Nishida N, Fukuda Y et al. (1996) Infrequent alterations of the p16INK4A gene in liver cancer. Int J Cancer 67: 176–180

    PubMed  CAS  Google Scholar 

  • Kojima H, Yokosuka O, Imazeki F, Saisho H, Ornata M (1997) Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112: 493–500

    PubMed  CAS  Google Scholar 

  • Kojiro M, Nakashima T (1987) Pathology of hepatocellular carcinoma. In: Nakashima T, Kojiro M (eds) Hepatocellular carcinoma. An atlas of its pathology. Springer, Berlin Heidelberg New York Tokyo, pp 81–100

    Google Scholar 

  • Komine F, Shimojima M, Moriyama M, Amaki S, Uchida T, Arakawa Y (2000) Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma.) Hepatol 32: 235–241

    CAS  Google Scholar 

  • Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON (1998) Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 42: 442–447

    PubMed  CAS  Google Scholar 

  • Kurtaran A, Li SR, Raderer M et al. (1995) Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr- (A14)-insulin visualizes human hepatocellular carcinomas.J Nucl Med 36: 1875–1881

    CAS  Google Scholar 

  • Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K (1999) Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29: 1858–1862

    PubMed  CAS  Google Scholar 

  • Lai CL, Lau JY, Wu PC et al. (1993) Recombinant interferon-alpha in inoperable hepatocellular carcinoma:a randomized controlled trial.Hepatology 17: 389–394

    CAS  Google Scholar 

  • Lau WY, LeungTW, Ho 5K et al. (1999) Adjuvant intra-arterial iodine-131–1abelled lipiodol for resectable hepatocellular carcinoma:a prospective randomised trial. Lancet 353: 797–801

    PubMed  CAS  Google Scholar 

  • Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW (1995) Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol 164: 215–220

    PubMed  CAS  Google Scholar 

  • Lelbach WK (1996) A 25-year follow-up study of heavily exposed vinyl Chloride workers in Germany. Am J lud Med 29: 446–458

    CAS  Google Scholar 

  • Lemon SM, Thomas DL (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336: 196–204

    PubMed  CAS  Google Scholar 

  • Lencioni R, Mascalchi M, Caramella D, Bartolozzi C (1996) Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPAenhanced MR imaging. Ab-dom Imaging 21: 41–48

    CAS  Google Scholar 

  • Liew CT, Li HM, Lo KW et al. (1999) High frequency of p 16INK4A gene alterations in hepatocellular carcinoma. Oncogene 18: 789–795

    PubMed  CAS  Google Scholar 

  • Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214: 869–874

    PubMed  CAS  Google Scholar 

  • Lin DY, LiawYF, Chu CM, Chung-Chien CS, Wu CS, Chen PC, Sheen IS (1984) Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan. Cancer 54: 1466–1468

    CAS  Google Scholar 

  • Lindner DJ, Borden EC (1997) Effects of tamoxifen and interferon-beta or the combination an tumor-induced angiogenesis. Int J Cancer 71: 456–461

    PubMed  CAS  Google Scholar 

  • LivraghiT, GiorgioA, Marin G et al. (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197: 101–108

    PubMed  CAS  Google Scholar 

  • Livraghi T, Lazzaroni S, Meloni F, Torzilli G, Vettori C (1995) Intralesional ethanol in the treatment of unresectable liver Cancer.World J Surg 19: 801–806

    CAS  Google Scholar 

  • Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83: 48–57

    PubMed  CAS  Google Scholar 

  • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210: 655–661

    PubMed  CAS  Google Scholar 

  • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, lerace T, Solbiati L, Gazelle GS (2000) Hepatocellular carcinoma:radio-frequency ablation of medium and large lesions. Radiology 214: 761–768

    PubMed  CAS  Google Scholar 

  • Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37: 429–442

    Google Scholar 

  • Llovet JM, Bruix J, FusterJ et al. (1998) Liver transplantation for small hepatocellular carcinoma: the tumor- node-metastasis classification does not have prognostic power. Hepatology 27: 1572–1577

    PubMed  CAS  Google Scholar 

  • Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, Bru C, Rodes J, Bruix I (1999) Natural history of untreated nonsurgical hepatocellular carcinoma:rationale for the design and evaluation oftherapeutic trials. Hepatology 29: 62–67

    PubMed  CAS  Google Scholar 

  • Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma:the BCLC staging classification. Semin Liver Dis 19: 329–338

    PubMed  CAS  Google Scholar 

  • Llovet JM, Bruix J, Gores GJ (2000a) Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 31: 1019–1021

    PubMed  CAS  Google Scholar 

  • Llovet JM, Sala M, Castells L et al. (2000b) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 31: 54–58

    PubMed  CAS  Google Scholar 

  • Llovet JM, Sala M, Castells L et al. (2000c) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 31: 54–58

    PubMed  CAS  Google Scholar 

  • Llovet JM, Real MI, Montana X et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734–1739

    PubMed  Google Scholar 

  • Luber B, Arnold N, Stürzl M et al. (1996) Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene 12: 1597–1608

    PubMed  CAS  Google Scholar 

  • Macdonald GA, Greenson JK, Saito K, Cherian SP, Appelman HD, Boland CR (1998) Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology 28: 90–97

    PubMed  CAS  Google Scholar 

  • Majno PE, Adam R, Bismuth H et al. (1997) Influence of preoperative transarterial lipiodol chemoembolization an resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688–701

    PubMed  CAS  Google Scholar 

  • Makuuchi M, Takayama T, Kosuge T, Yamazaki S, Yamamoto J, Hasegawa H, Takayasu K (1991) The value of ultrasonography for hepatic surgery. Hepatogastroenterology 38: 64–70

    PubMed  CAS  Google Scholar 

  • Manesis EK, Giannoulis G, Zoumboulis P, Vafiadou I, Hadziyannis S (1995) Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology 21: 1535–1542

    PubMed  CAS  Google Scholar 

  • Matsumura M, Niwa Y, Kato N et al. (1994) Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation:a possible predictor of metastatic hepatocellular carcinoma. Hepatology 20: 1418–1425

    PubMed  CAS  Google Scholar 

  • Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693–699

    PubMed  CAS  Google Scholar 

  • Mazzella G, Accogli E, Sottili S et al. (1996) Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 24: 141–147

    PubMed  CAS  Google Scholar 

  • McCaughan GW, Bilous MJ, Gallagher ND (1985) Long-term survival with tumor regression in androgen-induced liver tumors.Cancer 56: 2622–2626

    CAS  Google Scholar 

  • McGlynn KA, Rosvold EA, Lustbader ED et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B,. PNAS 92: 2384–2387

    PubMed  CAS  Google Scholar 

  • McMahon G, Davis EF, Huber U, Kim Y, Wogan GN (1990) Characterization of c-Ki-ras and Nras oncogenes in aflatoxin B 1-induced rat liver tumors. Proc Natl Acad Sei U S A 87: 1104–1108

    CAS  Google Scholar 

  • McMaster P (1996) More radical surgical excision for hepatocellular Cancer? Lancet 348: 1601–1602

    PubMed  CAS  Google Scholar 

  • Merine D, Takayasu K, Wakao F (1990) Detection of hepatocellular carcinoma: comparison of CT during arterial portography with CT after intraarterial injection of iodized oil. Radiology 175: 707–710

    PubMed  CAS  Google Scholar 

  • Miller WJ, Federle MP, Campbell WL (1991) Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 361 fiver transplantation patients. AJR Am J Roentgenol 157: 303–306

    PubMed  CAS  Google Scholar 

  • Miller WJ, Baron RL, Dodd GD, Federle MP (1994) Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193: 645–650

    PubMed  CAS  Google Scholar 

  • Minami M, Poussin K, Kew M, Okanoue T, Bréchot C, Paterlini P (1996) Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed an noncirrhotic livers. Gastroenterology 111: 691–700

    PubMed  CAS  Google Scholar 

  • Mion F, Grozel L, Boillot O, Paliard P, Berger F (1996) Adult cirrhotic liver ex-plants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 111: 1587–1592

    PubMed  CAS  Google Scholar 

  • Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.Cancer Res 51: 5520–5525

    CAS  Google Scholar 

  • Murakami T, Baron RL, Federle MP, Peterson MS, Oliver JH, Davis PL, Confer SR (1996a) Cirrhosis of the liver: MR imaging with mangafodipir trisodium ( Mn-DPDP ). Radiology 198: 567–572

    Google Scholar 

  • Murakami T, Baron RL, Peterson MS, Oliver JH, Davis PL, Confer SR, Federle MP (1996b) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium ( Mn- DPDP ). Radiology 200: 69–77

    Google Scholar 

  • Muto Y, Moriwaki H, Ninomiya M et al. (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334: 1561–1567

    Google Scholar 

  • Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A (1997) Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927–2933

    PubMed  CAS  Google Scholar 

  • Nagasue N, Uchida M, Makino Y et al. (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105: 488–494

    PubMed  CAS  Google Scholar 

  • Nerenstone SR, Ihde DC, Friedman MA (1988) Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 15: 1–31

    PubMed  CAS  Google Scholar 

  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256–1262

    PubMed  CAS  Google Scholar 

  • Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis.Gastroenterology 110: 1107–1119

    CAS  Google Scholar 

  • Nishiguchi S, Kuroki T, Nakatani S et al. (1995) Randomised trial of effects of interferon-alpha an incidence of hepatocellular carcinoma in chronic active hepatitis C with Cirrhosis. Lancet 346: 1051–1055

    PubMed  CAS  Google Scholar 

  • Nishiguchi S, Shiomi S, Nakatani S et al. (2001) Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 357: 196–197

    PubMed  CAS  Google Scholar 

  • Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M (1999) Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest 79: 15–26

    PubMed  CAS  Google Scholar 

  • Ohashi I, Hanafusa K, Yoshida T (1993) Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. Radiology 189: 851–855

    PubMed  CAS  Google Scholar 

  • Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H (1996) Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AIR Am J Roentgenol 166: 369–374

    CAS  Google Scholar 

  • Ojanguren I, Ariza A, Castellà EM, Fernandez Vasaio A, Mate JL, Navas Palacios JJ (1995) Immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. Histopathology 26: 63–68

    PubMed  CAS  Google Scholar 

  • Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S (1994) Prospective study of aiphafetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19: 61–66

    PubMed  CAS  Google Scholar 

  • Okada S, Shimada K, Yamamoto J et al. (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106: 1618–1624

    PubMed  CAS  Google Scholar 

  • Okuda K, Peters RL, Simson IW (1984) Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification.Cancer 54: 2165–2173

    CAS  Google Scholar 

  • Okuda K, Ohtsuki T, Obata H et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56: 918–928

    PubMed  CAS  Google Scholar 

  • Okuda K (1992) Hepatocellular carcinoma:recent progress.Hepatology 15: 948–963

    CAS  Google Scholar 

  • Oldhafer KJ, Chavan A, Fruhauf NR et al. (1998) Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 29: 953–959

    PubMed  CAS  Google Scholar 

  • Oliver JH, Baron RL, Federle MP, Rockette HE Jr (1996) Detecting hepatocellular carcinoma: value of unenhanced or Arerial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 167: 71–77

    PubMed  Google Scholar 

  • Olthoff KM, Rosove MH, Shackleton CR et al. (1995) Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 221:734–741; discussion 731–743

    Google Scholar 

  • Outwater EK, Ito K, Siegelman E, Martin CE, Bhatia M, Mitchell DG (1997) Rapidly enhancing hepatic hemangiomas at MRI: distinction from malignancies with T2-weighted images. J Magn Reson Imaging 7: 1033–1039

    PubMed  CAS  Google Scholar 

  • Ozturk M (1999) Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19: 235–242

    PubMed  CAS  Google Scholar 

  • Peck-Radosavljevic M, Pidlich J, Bergmann M et al. (1998) Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than detection of albumin mRNA in peripheral blood.J Hepatol 28: 497–503

    CAS  Google Scholar 

  • Perret AG, Mosnier JF, Porcheron J, Cuilleron M, Berthoux P, Boucheron S, Audigier JC (1996) Role of oral contraceptives in the growth of a multi-lobular adenoma associated with a hepatocellular carcinoma in a young woman.J Hepatol 25: 976–979

    CAS  Google Scholar 

  • Pietenpol JA, Vogelstein B (1993)Tumour suppressor genes. No room at the p53 inn. Nature 365: 17–18

    Google Scholar 

  • Pirastu R, Comba P, Reggiani A, Foa V, Masina A, Maltoni C (1990) M.ortality from liver disease among Italian vinyl chloride monomer/polyvinyl chloride manufacturers. Am J Ind Med 17: 155–161

    PubMed  CAS  Google Scholar 

  • Pocock S, White I (1999) Trials stopped early: too good to be true?. Lancet 353: 943–944

    PubMed  CAS  Google Scholar 

  • Pontisso P, Belluco C, Bertorelle R et al. (1998) Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients.Cancer 83: 1489–1494

    CAS  Google Scholar 

  • Prorok PC (1992) Epidemiologic approach for Cancer screening. Problems in design and analysis of trials. Am J Pediatr Haematol Oncol 14: 117–128

    CAS  Google Scholar 

  • Reinhold C, Hammers L, Taylor CR, Quedens Case CL, Holland CK, Taylor KJ (1995) Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients. AJR Am J Roentgenol 164: 1131–1135

    PubMed  CAS  Google Scholar 

  • Rifkin MD, Rosato FE, Branch HM, Foster J, Yang SL, Barbot DJ, Marks GJ (1987) Intraoperative ultrasound of the liver.An important adjunctive tool for decision making in the operating room. Ann Surg 205: 466–472

    PubMed  CAS  Google Scholar 

  • Ringe B, Pichlmayr R, Wittekind C, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15: 270–285

    PubMed  CAS  Google Scholar 

  • Rizzi PM, Kane PA, Ryder SD et al. (1994) Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 107: 1425–1429

    PubMed  CAS  Google Scholar 

  • Rizzi PM, Ryder SD, Ramage JK et al. (1994) Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.Transplant Proc 26: 3568–3569

    CAS  Google Scholar 

  • Robinson PJ (1996)The characterization of liver tumours by MRI.Clin Radiol 51:749–761

    Google Scholar 

  • Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME (1993) Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 188: 53–59

    PubMed  CAS  Google Scholar 

  • Rogler CE, Chisari FV (1992) Cellular and molecular mechanisms of hepatocarcinogenesis. Sem Liver Dis 12: 265–278

    CAS  Google Scholar 

  • Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) Epidemiology of hepatocellular adenoma.The role of oral contraceptive use. JAMA 242: 644–648

    PubMed  CAS  Google Scholar 

  • Ros PR, Freeny PC, Harms SE et al. (1995) Hepatic MR imaging with ferumoxides:a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196: 481–488

    PubMed  CAS  Google Scholar 

  • Rossi S, Di Stasi M, Buscarini E et al. (1995) Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1: 73

    PubMed  CAS  Google Scholar 

  • Saini S, Stark DD, Hahn PF et al. (1987) Ferrite particles:a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.Radiology 162: 217–222

    CAS  Google Scholar 

  • Saini S (1997) Imaging of the hepatobiliary tract. N Engl J Med 336: 1889–1894

    PubMed  CAS  Google Scholar 

  • Sakakura C, Hagiwara A, Taniguchi H et al. (1999) Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br, i Cancer 80: 2034–2039

    CAS  Google Scholar 

  • Sakamoto M, Hirohashi S, Tsuda H, Shimosato Y, Makuuchi M, Hosoda Y (1989) Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol 13: 1064–1067

    PubMed  CAS  Google Scholar 

  • Sakon M, Monden M, Gotoh M et al. (1992) Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha- fetoprotein in hepatocellular carcinoma. Am J Surg 163: 251–256

    PubMed  CAS  Google Scholar 

  • Salvucci M, Lemoine A, Saffroy R et al. (1999) Microsatellite instability in European hepatocellular carcinoma. Oncogene 18: 181–187

    PubMed  CAS  Google Scholar 

  • Sato Y, Nakata K, Kato Y et al. (1993) Early recognition of hepatocellular carcinoma based an altered profiles of alpha-fetoprotein. N Engl J Med 328: 1802–1806

    PubMed  CAS  Google Scholar 

  • Saurin JC, Taniere P, Mion F, Jacob P, Partensky C, Paliard P, Berger F (1997) Primary hepatocellular carcinoma in workers exposed to vinyl chloride:a report of two cases. Cancer 79: 1671–1677

    PubMed  CAS  Google Scholar 

  • Scheuer PJ, Lefkowitch JH (1994) Neoplasms and nodules. In: Scheuer PJ, Lefkowitch JH (eds) Liver biopsy interpretation, vol 31. Major problems in pathology, 5th edn. WB Saunders, London, pp 152–181

    Google Scholar 

  • Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A (2001) Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 48: 103–109

    PubMed  CAS  Google Scholar 

  • Schwickert H, Thelen M (1993) Diagnosis and follow-up of tumors and metastases of the liver using imaging techniques. Aktuelle Radiol 3: 144–151

    PubMed  CAS  Google Scholar 

  • Seneterre E, Taourel P, Bouvier Y et al. (1996) Detection of hepatic metastases:ferumoxidesenhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200: 785–792

    PubMed  CAS  Google Scholar 

  • Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 305: 1067–1073

    Google Scholar 

  • Shapiro RS, Katz R, Mendelson DS, Halton KP, Schwartz ME, Miller CM (1996) Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. J Ultrasound Med 15: 497–502; quiz 503–494

    Google Scholar 

  • Sherlock S, Dooley J (1997) Diseases of the liver and biliary system, 10th edn. Blackwell Science, Oxford

    Google Scholar 

  • Sheu JC, Sung JL, Chen DS et al. (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89: 259–266

    PubMed  CAS  Google Scholar 

  • Shimada M, Hasegawa H, Gion T et al. (2000) The role of telomerase activity in hepatocellular carcinoma. Am J Gastroenterol 95: 748–752

    PubMed  CAS  Google Scholar 

  • Shinagawa T, Ohto M, Kimura K et al. (1984) Diagnosis and clinical features of small hepatocellular carcinoma with emphasis an the utility of realtime ultrasonography. A study in 51 patients. Gastroenterology 86: 495–502

    PubMed  CAS  Google Scholar 

  • Sitzmann JV, Abrams R (1993) Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 217: 149–154

    PubMed  CAS  Google Scholar 

  • Slagle BL, Zhou YZ, Butel JS (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 51: 49–54

    PubMed  CAS  Google Scholar 

  • Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK (1994) Primary malignant neoplasms of the liver:detection with helical CT during arterial portography. Radiology 192: 389–392

    PubMed  CAS  Google Scholar 

  • Spreafico C, Marchianò A, Mazzaferro V et al. (1997) Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil. Radiology 203: 457–460

    PubMed  CAS  Google Scholar 

  • Stevens WR, Johnson CD, Stephens DH, Nagorney DM (1995) Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. Am J Roentgenol 164: 1153–1158

    CAS  Google Scholar 

  • Stone MJ, Klintmalm GB, Polter D et al. (1993) Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma:a pilot study in 20 patients. Gastroenterology 104: 196–202

    PubMed  CAS  Google Scholar 

  • Strand S, Hofmann WJ, Hug H et al. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells–a mechanism of immune evasion? Nat Med 2: 1361–1366

    PubMed  CAS  Google Scholar 

  • Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77: 2217–2222

    Google Scholar 

  • Su TS, Hwang WL, YaukYK (1998) Characterization of hepatitis B virus integrant that results in chromosomal rearrangement. DNA Cell Biol 17: 415–425

    PubMed  CAS  Google Scholar 

  • Suda T, Isokawa O, Aoyagi Y et al. (1998) Quantitation of telomerase activity in hepatocellular carcinoma:a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 27: 402–406

    PubMed  CAS  Google Scholar 

  • Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T (1994) Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma.Comparison with alpha-fetoprotein. Cancer 73: 2464–2471

    PubMed  CAS  Google Scholar 

  • Sumida M, Ohto M, Ebara M, Kimura K, Okuda K, Hirooka N (1986) Accuracy of angiography in the diagnosis of small hepatocellular carcinoma.Am J Roentgenol 147: 531–536

    CAS  Google Scholar 

  • Tada M, Ornata M, Ohto M (1990) Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 50: 1121–1124

    PubMed  CAS  Google Scholar 

  • Takada S, Koike K (1989) Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells.Oncogene 4: 189–193

    CAS  Google Scholar 

  • Takahashi K, Saito K, Tamura K et al. (1990) Hepatic neoplasms: detection with hepatoportal subtraction angiography–a new technique of DSA. Radiology 177: 243–248

    PubMed  CAS  Google Scholar 

  • Takano S, Yokosuka O, Imazeki F, Tagawa M, Ornata M (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21: 650–655

    PubMed  CAS  Google Scholar 

  • TakayamaT, Makuuchi M, Hirohashi S et al. (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336: 1150–1153

    Google Scholar 

  • Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S (1990)Thediagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 155: 49–54

    Google Scholar 

  • Takayasu K, Muramatsu Y, Furukawa H et al. (1995) Early hepatocellular carcinoma:appearance at CT during arterial portography and CT arteriography with pathologic correlation. Radiology 194: 101–105

    PubMed  CAS  Google Scholar 

  • Taketa K (1990) Alpha-fetoprotein: reevaluation in hepatology. Hepatology 12: 1420–1432

    PubMed  CAS  Google Scholar 

  • Tanaka K, Sata M, Uchimura Y, Suzuki H, Tanikawa K (1998) Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? Oncol Rep 5: 205–208

    PubMed  CAS  Google Scholar 

  • Tanaka S, Oshikawa O, Sasaki T, loka T, Tsukuma H (2000) Evaluation of tissue harmonic imaging for the diagnosis of focal liver lesions. Ultrasound Med Biol 26: 183–187

    PubMed  CAS  Google Scholar 

  • Tang Y, Yamashita Y, Arakawa A et al. (1999) Detection of hepatocellular carcinoma arising in cirrhosic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Am J Roentgenol 172: 1547–1554

    CAS  Google Scholar 

  • The Cancer of the Liver Italian Program (CLIP) Investigators (2000) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840–845

    Google Scholar 

  • Thorgeirsson SS (2003) Hunting for tumor suppressor genes in liver cancer. Hepatology 37: 739–741

    PubMed  CAS  Google Scholar 

  • Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339–346

    PubMed  CAS  Google Scholar 

  • Troisi R, Defreyne L, Hesse UJ, Praet M, Decruyenaere J, De Hemptinne B (1998) Multimodal treatment for hepatocellular carcinoma an cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.Clin Transplant 12: 313–319

    CAS  Google Scholar 

  • Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH (1997) Effect of hepatitis C and B virus infection an risk of hepatocellular carcinoma:a prospective study. Br J Cancer 76: 968–974

    PubMed  CAS  Google Scholar 

  • Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyanrura T, Hirohashi S (1990) Allele loss an chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791–6794

    PubMed  CAS  Google Scholar 

  • Tsukuma H, Hiyama T, Tanaka S et al. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328: 1797–1801

    PubMed  CAS  Google Scholar 

  • Tublin ME, Dodd GD, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. Am J Roentgenol 168: 719–723

    CAS  Google Scholar 

  • Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9: 41–47

    PubMed  CAS  Google Scholar 

  • Unsal H, Yakicier C, Margais C et al. (1994) Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 91: 822–826

    PubMed  CAS  Google Scholar 

  • Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der WattJJ, VincentTJ, Purchase IF (1985) Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51: 713–726

    Google Scholar 

  • Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28–34; discussion 34–35

    Google Scholar 

  • Vautier G, Bomford AB, Portmann BC, Metivier E, Williams R, Ryder SD (1999) P53 mutations in British patients with hepatocellular carcinoma:clustering in genetic hemochromatosis.Gastroenterology 117: 154–160

    CAS  Google Scholar 

  • Vian A, Lorenoni U, Lobello S, Floreani A, Farinati F, Naccarato R, Chiara-monte M (1996) Hepatocellular carcinoma (HCC) in HCV-related cirrhosis treated and not treated with Interferon.Gut 39 [Suppl]: A25

    Google Scholar 

  • Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J (1992) Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 16: 353–357

    PubMed  CAS  Google Scholar 

  • Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR (1994) P53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot Spot mutation. Oncogene 9: 195–204

    PubMed  CAS  Google Scholar 

  • Ward J, Baudouin CJ, Ridgway JP, Robinson PJ (1995) Magnetic resonance imaging in the detection of focal liver lesions:comparison of dynamic contrast-enhanced TurboFLASH and T2 weighted spin echo images. Br J Radiol 68: 463–470

    PubMed  CAS  Google Scholar 

  • Westaby D, Portmann B, Williams R (1983) Androgen related primary hepatic tumors in nonFanconi patients. Cancer 51: 1947–1952

    PubMed  CAS  Google Scholar 

  • Yamada S, Hosoda S, Tateno H, Kido C, Takahashi S (1983) Survey of thorotrast-associated liver cancers in Japan. J Natl Cancer Inst 70: 31–35

    PubMed  CAS  Google Scholar 

  • Yamada T, De Souza AT, Finkelstein S, Jirtle RL (1997) Loss of the gene encoding mannose 6-phosphate/Insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 94: 10351–10355

    PubMed  CAS  Google Scholar 

  • Yamamoto H, Yamashita Y, Yoshimatsu S et al. (1995) Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and fron oxide-enhanced MR imaging. Radiology 195: 106–112

    PubMed  CAS  Google Scholar 

  • Yamamoto H, Itoh F, Fukushima H et al. (2000) Infrequent widespread microsatellite instability in hepatocellular carcinomas. Int J Oncol 16: 543–547

    PubMed  CAS  Google Scholar 

  • Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, Takahashi M (1996) Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200: 79–84

    PubMed  CAS  Google Scholar 

  • Yao FY, Ferrell L, Bass NM et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394–1403

    PubMed  CAS  Google Scholar 

  • Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE (1991) Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation.Cancer 68: 2095–2100

    CAS  Google Scholar 

  • Yuen MF, Poon RT, Lai CLet al. (2002) A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology 36: 687–691

    PubMed  CAS  Google Scholar 

  • Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y (1990) Growth and spread of hepatocellular carcinoma, A review of 240 consecutive autopsy cases. Cancer 66: 2174–2179

    PubMed  CAS  Google Scholar 

  • Yumoto Y, Jinno K, Tokuyama K et al. (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 19–24

    PubMed  CAS  Google Scholar 

  • Zhou XD, Tang ZY, Yu YQ, Ma ZC (1988) Clinical evaluation of cryosurgery in the treatment of primary liver Cancer. Report of 60 cases. Cancer 61: 1889–1892

    PubMed  CAS  Google Scholar 

  • Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E (1996) Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 78: 977–985

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Peck-Radosavljevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Schima
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Peck-Radosavljevic, M., Schima, W. (2004). Hepatozelluläres Karzinom. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06670-6_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-06671-3

  • Online ISBN: 978-3-662-06670-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation